H.R. 5196 — Introduced in House

I 116th CONGRESS 1st Session H. R. 5196 IN THE HOUSE OF REPRESENTATIVES November 20, 2019Mr. Delgado (for himself and Mr. Rose of New York) introduced the following bill; which was referred to the Committee on House Administration A BILL To amend the Federal Election Campaign Act of 1971 to prohibit a separate segregated fund of a corporation which is engaged in the manufacture of opioids from making contributions or expenditures in connection with elections for Federal office, and for other purposes. 1. Short title This Act may be cited as the Save Lives Act. 2. Prohibiting campaign spending by separate segregated funds of corporations engaged in manufacture of opioids (a) Prohibition Section 316(b) of the Federal Election Campaign Act of 1971 (52 U.S.C. 30118(b)) is amended— (1) in paragraph (2)(C), by striking the establishment and inserting subject to paragraph (8), the establishment; and (2) by adding at the end the following new paragraph: (8) (A) A separate segregated fund of a corporation may not solicit any contribution, and may not make any contribution or expenditure, at any time during which the corporation is engaged in the manufacture of opioids. (B) In this paragraph— (i) the term manufacture has the meaning given such term in section 102(15) of the Controlled Substances Act (21 U.S.C. 802(15)); and (ii) the term opioid has the meaning given such term in section 102(18) of the Controlled Substances Act (21 U.S.C. 802(18)). . (b) Effective date The amendments made by this section shall apply with respect to contributions solicited, and contributions and expenditures made, on or after the date of the enactment of this Act.